# Sandra Demaria

Source: https://onco.cc/people/sandra-demaria/  
OnCo record `sandra-demaria` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Weill Cornell pathologist-immunologist known for radiation-immunotherapy research; SITC Vice President.

## Summary

Sandra Demaria is Vice President of the Society for Immunotherapy of Cancer for 2025-2026 and a professor at Weill Cornell Medicine. Her laboratory studies how radiotherapy modulates anti-tumour immunity and how it can be combined with immune checkpoint blockade, with a strong focus on breast cancer. She is a widely cited contributor to the field of radiation-induced in situ vaccination.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Tags: leadership; clinician-scientist; immunotherapy; radiotherapy
- Role: Vice President (2025-2026)
- Specialisms: Radiation and immunotherapy combinations; Tumour immunology; Breast cancer

## Sources

- Society page: https://www.sitcancer.org/about/board
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Demaria+S%5BAuthor%5D

## Connected records

- cancers: [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- institutions: [Society for Immunotherapy of Cancer](https://onco.cc/institutions/sitc/)

---
JSON: https://onco.cc/api/v1/entities/sandra-demaria.json